Motivators to Participation in Actual HIV Vaccine Trials

被引:19
作者
Dhalla, Shayesta [1 ]
Poole, Gary [2 ]
机构
[1] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada
关键词
HIV; Vaccine; Actual; Motivators; Social; Personal; EFFICACY TRIAL; HIGH-RISK; THAILAND; VOLUNTEERS; RECRUITMENT; BEHAVIOR; ENROLLMENT; INFECTION; TANZANIA; REASONS;
D O I
10.1007/s10461-013-0519-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
An examination of actual HIV vaccine trials can contribute to an understanding of motivators for participation in these studies. Analysis of these motivators reveals that they can be categorized as social and personal benefits. Social benefits are generally altruistic, whereas personal benefits are psychological, physical, and financial. In this systematic review, the authors performed a literature search for actual preventive HIV vaccine trials reporting motivators to participation. Of studies conducted in the Organization for Economic Co-operation and Development (OECD) countries, the authors retrieved 12 studies reporting on social benefits and seven reporting on personal benefits. From the non-OECD countries, nine studies reported on social benefits and eight studies on personal benefits. Social benefits were most frequently described on macroscopic, altruistic levels. Personal benefits were most frequently psychological in nature. Rates of participation were compared between the OECD and the non-OECD countries. Knowledge of actual motivators in specific countries and regions can help target recruitment in various types of actual HIV vaccine trials.
引用
收藏
页码:263 / 277
页数:15
相关论文
共 25 条
[1]   Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania [J].
Bakari, Muhammad ;
Aboud, Said ;
Nilsson, Charlotta ;
Francis, Joel ;
Buma, Deus ;
Moshiro, Candida ;
Aris, Eric A. ;
Lyamuya, Eligius F. ;
Janabi, Mohamed ;
Godoy-Ramirez, Karina ;
Joachim, Agricola ;
Polonis, Victoria R. ;
Brave, Andreas ;
Earl, Patricia ;
Robb, Merlin ;
Marovich, Mary ;
Wahren, Britta ;
Pallangyo, Kisali ;
Biberfeld, Gunnel ;
Mhalu, Fred ;
Sandstrom, Eric .
VACCINE, 2011, 29 (46) :8417-8428
[2]   HEALTH BELIEF MODEL AND SICK ROLE BEHAVIOR [J].
BECKER, MH .
HEALTH EDUCATION MONOGRAPHS, 1974, 2 (04) :409-419
[3]   Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers [J].
Belshe, RB ;
Stevens, C ;
Gorse, GJ ;
Buchbinder, S ;
Weinhold, K ;
Sheppard, H ;
Stablein, D ;
Self, S ;
McNamara, J ;
Frey, S ;
Flores, J ;
Excler, JL ;
Klein, M ;
El Habib, R ;
Duliege, AM ;
Harro, C ;
Corey, L ;
Keefer, M ;
Mulligan, M ;
Wright, P ;
Celum, C ;
Judson, F ;
Mayer, K ;
McKirnan, D ;
Marmor, M ;
Woody, G .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09) :1343-1352
[4]   Determinants of enrollment in a preventive HIV vaccine trial [J].
Buchbinder, SP ;
Metch, B ;
Holte, SE ;
Scheer, S ;
Coletti, A ;
Vittinghoff, E .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) :604-612
[5]   Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note [J].
Chesney, MA ;
Chambers, DB ;
Kahn, JO .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (04) :266-271
[6]   Lessons from a multisite International trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120 [J].
Cleghorn, Farley ;
Pape, Jean W. ;
Schechter, Mauro ;
Bartholomew, Courtenay ;
Sanchez, Jorge ;
Jack, Noreen ;
Metch, Barbara J. ;
Hansen, Marianne ;
Allen, Mary ;
Cao, Huyen ;
Montefiori, David C. ;
Tomaras, Georgia D. ;
Gurunathan, Sanjay ;
Eastman, Donna J. ;
do Lago, Regina F. ;
Jean, Sonic ;
Lama, Javier R. ;
Lawrence, Dale N. ;
Wright, Peter F. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) :222-230
[7]   Motivations for participating in an HIV vaccine efficacy trial [J].
Colfax, G ;
Buchbinder, S ;
Vamshidar, G ;
Celum, C ;
McKirnan, D ;
Neidig, J ;
Koblin, B ;
Gurwith, M ;
Bartholow, B .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) :359-364
[8]   Reasons for Not Participating in a Phase 1 Preventive HIV Vaccine Study in a Resource-Rich Country [J].
Constanza Lucero, Maria ;
Diaz-Brito, Vicens ;
Torres Murillo, Berta ;
Corral Carretero, Saray ;
Sala, Marta ;
Casadesus, Cristina ;
Sanchez Conde, Matilde ;
Luis Jimenez, Jose ;
Pich, Judit ;
Albert Arnaiz, Joan ;
Leon, Agathe ;
Perez, Inaki ;
Munoz-Fernandez, Ma Angeles ;
Gatell, Jose M. ;
Plana, Montserrat ;
Esteban, Mariano ;
Bernaldo de Quiros, Juan Carlos ;
Garcia, Felipe .
AIDS PATIENT CARE AND STDS, 2012, 26 (07) :379-382
[9]  
Crumbo C L, 1997, J Assoc Nurses AIDS Care, V8, P59, DOI 10.1016/S1055-3290(97)80029-5
[10]   Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies [J].
Dhalla, Shayesta ;
Poole, Gary .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2011, 23 (11) :1430-1447